nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C9—Capecitabine—colon cancer	0.157	0.321	CbGbCtD
Fenofibrate—CYP2C8—Fluorouracil—colon cancer	0.133	0.273	CbGbCtD
Fenofibrate—CYP2C9—Fluorouracil—colon cancer	0.0928	0.19	CbGbCtD
Fenofibrate—CYP3A4—Irinotecan—colon cancer	0.0562	0.115	CbGbCtD
Fenofibrate—CYP3A4—Vincristine—colon cancer	0.0492	0.101	CbGbCtD
Fenofibrate—PPARA—blood vessel—colon cancer	0.0143	0.196	CbGeAlD
Fenofibrate—PPARA—embryo—colon cancer	0.00852	0.117	CbGeAlD
Fenofibrate—PPARA—epithelium—colon cancer	0.00695	0.0955	CbGeAlD
Fenofibrate—PPARA—smooth muscle tissue—colon cancer	0.0067	0.092	CbGeAlD
Fenofibrate—PPARA—renal system—colon cancer	0.00645	0.0886	CbGeAlD
Fenofibrate—PPARA—lymphoid tissue—colon cancer	0.00536	0.0736	CbGeAlD
Fenofibrate—PPARA—digestive system—colon cancer	0.00529	0.0727	CbGeAlD
Fenofibrate—Bezafibrate—PPARG—colon cancer	0.00492	0.431	CrCbGaD
Fenofibrate—PPARA—liver—colon cancer	0.00394	0.0541	CbGeAlD
Fenofibrate—Indomethacin—PPARG—colon cancer	0.00365	0.319	CrCbGaD
Fenofibrate—PPARA—lymph node—colon cancer	0.00302	0.0415	CbGeAlD
Fenofibrate—CYP2C8—renal system—colon cancer	0.00234	0.0321	CbGeAlD
Fenofibrate—CYP2C9—digestive system—colon cancer	0.0017	0.0234	CbGeAlD
Fenofibrate—CYP2C8—vagina—colon cancer	0.00169	0.0233	CbGeAlD
Fenofibrate—CYP3A4—renal system—colon cancer	0.00158	0.0218	CbGeAlD
Fenofibrate—Indomethacin—PTGS2—colon cancer	0.00154	0.135	CrCbGaD
Fenofibrate—CYP2C8—liver—colon cancer	0.00143	0.0196	CbGeAlD
Fenofibrate—Indomethacin—ABCB1—colon cancer	0.00131	0.115	CrCbGaD
Fenofibrate—CYP3A4—digestive system—colon cancer	0.0013	0.0178	CbGeAlD
Fenofibrate—CYP2C9—liver—colon cancer	0.00127	0.0174	CbGeAlD
Fenofibrate—CYP3A4—liver—colon cancer	0.000968	0.0133	CbGeAlD
Fenofibrate—Dysuria—Capecitabine—colon cancer	0.000818	0.00194	CcSEcCtD
Fenofibrate—Renal failure acute—Methotrexate—colon cancer	0.000816	0.00193	CcSEcCtD
Fenofibrate—Leukopenia—Irinotecan—colon cancer	0.000815	0.00193	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Capecitabine—colon cancer	0.000813	0.00192	CcSEcCtD
Fenofibrate—Hypertension—Vincristine—colon cancer	0.000807	0.00191	CcSEcCtD
Fenofibrate—Anaemia—Fluorouracil—colon cancer	0.000806	0.00191	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Capecitabine—colon cancer	0.000798	0.00189	CcSEcCtD
Fenofibrate—Myalgia—Vincristine—colon cancer	0.000796	0.00188	CcSEcCtD
Fenofibrate—Weight increased—Capecitabine—colon cancer	0.000796	0.00188	CcSEcCtD
Fenofibrate—Cough—Irinotecan—colon cancer	0.000795	0.00188	CcSEcCtD
Fenofibrate—Weight decreased—Capecitabine—colon cancer	0.000791	0.00187	CcSEcCtD
Fenofibrate—Hypertension—Irinotecan—colon cancer	0.000786	0.00186	CcSEcCtD
Fenofibrate—Pneumonia—Capecitabine—colon cancer	0.000784	0.00186	CcSEcCtD
Fenofibrate—Leukopenia—Fluorouracil—colon cancer	0.000781	0.00185	CcSEcCtD
Fenofibrate—Infestation NOS—Capecitabine—colon cancer	0.00078	0.00185	CcSEcCtD
Fenofibrate—Infestation—Capecitabine—colon cancer	0.00078	0.00185	CcSEcCtD
Fenofibrate—Acute coronary syndrome—Capecitabine—colon cancer	0.000769	0.00182	CcSEcCtD
Fenofibrate—Renal failure—Capecitabine—colon cancer	0.000767	0.00181	CcSEcCtD
Fenofibrate—Discomfort—Irinotecan—colon cancer	0.000766	0.00181	CcSEcCtD
Fenofibrate—Myocardial infarction—Capecitabine—colon cancer	0.000765	0.00181	CcSEcCtD
Fenofibrate—Oedema—Vincristine—colon cancer	0.000763	0.00181	CcSEcCtD
Fenofibrate—Jaundice—Capecitabine—colon cancer	0.00076	0.0018	CcSEcCtD
Fenofibrate—Infection—Vincristine—colon cancer	0.000758	0.00179	CcSEcCtD
Fenofibrate—Conjunctivitis—Capecitabine—colon cancer	0.000758	0.00179	CcSEcCtD
Fenofibrate—Urinary tract infection—Capecitabine—colon cancer	0.000758	0.00179	CcSEcCtD
Fenofibrate—Osteoarthritis—Methotrexate—colon cancer	0.000753	0.00178	CcSEcCtD
Fenofibrate—Nervous system disorder—Vincristine—colon cancer	0.000748	0.00177	CcSEcCtD
Fenofibrate—Thrombocytopenia—Vincristine—colon cancer	0.000747	0.00177	CcSEcCtD
Fenofibrate—Oedema—Irinotecan—colon cancer	0.000743	0.00176	CcSEcCtD
Fenofibrate—Chest pain—Fluorouracil—colon cancer	0.000743	0.00176	CcSEcCtD
Fenofibrate—Myalgia—Fluorouracil—colon cancer	0.000743	0.00176	CcSEcCtD
Fenofibrate—Infection—Irinotecan—colon cancer	0.000738	0.00175	CcSEcCtD
Fenofibrate—Hyperhidrosis—Vincristine—colon cancer	0.000738	0.00175	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Capecitabine—colon cancer	0.000738	0.00175	CcSEcCtD
Fenofibrate—Discomfort—Fluorouracil—colon cancer	0.000734	0.00174	CcSEcCtD
Fenofibrate—Nervous system disorder—Irinotecan—colon cancer	0.000729	0.00172	CcSEcCtD
Fenofibrate—Thrombocytopenia—Irinotecan—colon cancer	0.000728	0.00172	CcSEcCtD
Fenofibrate—Anorexia—Vincristine—colon cancer	0.000727	0.00172	CcSEcCtD
Fenofibrate—Hyperhidrosis—Irinotecan—colon cancer	0.000718	0.0017	CcSEcCtD
Fenofibrate—Hypotension—Vincristine—colon cancer	0.000713	0.00169	CcSEcCtD
Fenofibrate—Oedema—Fluorouracil—colon cancer	0.000712	0.00168	CcSEcCtD
Fenofibrate—Anorexia—Irinotecan—colon cancer	0.000708	0.00168	CcSEcCtD
Fenofibrate—Infection—Fluorouracil—colon cancer	0.000707	0.00167	CcSEcCtD
Fenofibrate—Rhinitis—Capecitabine—colon cancer	0.000702	0.00166	CcSEcCtD
Fenofibrate—Hepatitis—Capecitabine—colon cancer	0.0007	0.00166	CcSEcCtD
Fenofibrate—Nervous system disorder—Fluorouracil—colon cancer	0.000698	0.00165	CcSEcCtD
Fenofibrate—Thrombocytopenia—Fluorouracil—colon cancer	0.000697	0.00165	CcSEcCtD
Fenofibrate—Liver function test abnormal—Methotrexate—colon cancer	0.000696	0.00165	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Vincristine—colon cancer	0.000695	0.00165	CcSEcCtD
Fenofibrate—Pharyngitis—Capecitabine—colon cancer	0.000695	0.00164	CcSEcCtD
Fenofibrate—Tachycardia—Fluorouracil—colon cancer	0.000695	0.00164	CcSEcCtD
Fenofibrate—Hypotension—Irinotecan—colon cancer	0.000694	0.00164	CcSEcCtD
Fenofibrate—Insomnia—Vincristine—colon cancer	0.00069	0.00163	CcSEcCtD
Fenofibrate—Oedema peripheral—Capecitabine—colon cancer	0.00069	0.00163	CcSEcCtD
Fenofibrate—Connective tissue disorder—Capecitabine—colon cancer	0.000688	0.00163	CcSEcCtD
Fenofibrate—Paraesthesia—Vincristine—colon cancer	0.000685	0.00162	CcSEcCtD
Fenofibrate—Anorexia—Fluorouracil—colon cancer	0.000679	0.00161	CcSEcCtD
Fenofibrate—Visual impairment—Capecitabine—colon cancer	0.000675	0.0016	CcSEcCtD
Fenofibrate—Insomnia—Irinotecan—colon cancer	0.000672	0.00159	CcSEcCtD
Fenofibrate—Paraesthesia—Irinotecan—colon cancer	0.000667	0.00158	CcSEcCtD
Fenofibrate—Hypotension—Fluorouracil—colon cancer	0.000665	0.00157	CcSEcCtD
Fenofibrate—Decreased appetite—Vincristine—colon cancer	0.000663	0.00157	CcSEcCtD
Fenofibrate—Dyspnoea—Irinotecan—colon cancer	0.000663	0.00157	CcSEcCtD
Fenofibrate—Somnolence—Irinotecan—colon cancer	0.000661	0.00156	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Vincristine—colon cancer	0.000659	0.00156	CcSEcCtD
Fenofibrate—Fatigue—Vincristine—colon cancer	0.000658	0.00156	CcSEcCtD
Fenofibrate—Eye disorder—Capecitabine—colon cancer	0.000654	0.00155	CcSEcCtD
Fenofibrate—Dyspepsia—Irinotecan—colon cancer	0.000654	0.00155	CcSEcCtD
Fenofibrate—Pain—Vincristine—colon cancer	0.000653	0.00154	CcSEcCtD
Fenofibrate—Constipation—Vincristine—colon cancer	0.000653	0.00154	CcSEcCtD
Fenofibrate—Asthma—Methotrexate—colon cancer	0.000651	0.00154	CcSEcCtD
Fenofibrate—Cardiac disorder—Capecitabine—colon cancer	0.00065	0.00154	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000649	0.00153	CcSEcCtD
Fenofibrate—Decreased appetite—Irinotecan—colon cancer	0.000646	0.00153	CcSEcCtD
Fenofibrate—Eosinophilia—Methotrexate—colon cancer	0.000645	0.00153	CcSEcCtD
Fenofibrate—Insomnia—Fluorouracil—colon cancer	0.000644	0.00152	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Irinotecan—colon cancer	0.000642	0.00152	CcSEcCtD
Fenofibrate—Fatigue—Irinotecan—colon cancer	0.000641	0.00152	CcSEcCtD
Fenofibrate—Paraesthesia—Fluorouracil—colon cancer	0.000639	0.00151	CcSEcCtD
Fenofibrate—Pancreatitis—Methotrexate—colon cancer	0.000638	0.00151	CcSEcCtD
Fenofibrate—Pain—Irinotecan—colon cancer	0.000636	0.0015	CcSEcCtD
Fenofibrate—Constipation—Irinotecan—colon cancer	0.000636	0.0015	CcSEcCtD
Fenofibrate—Angiopathy—Capecitabine—colon cancer	0.000635	0.0015	CcSEcCtD
Fenofibrate—Dyspnoea—Fluorouracil—colon cancer	0.000635	0.0015	CcSEcCtD
Fenofibrate—Somnolence—Fluorouracil—colon cancer	0.000633	0.0015	CcSEcCtD
Fenofibrate—Mediastinal disorder—Capecitabine—colon cancer	0.000631	0.00149	CcSEcCtD
Fenofibrate—Dyspepsia—Fluorouracil—colon cancer	0.000627	0.00148	CcSEcCtD
Fenofibrate—Arrhythmia—Capecitabine—colon cancer	0.000625	0.00148	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Vincristine—colon cancer	0.000624	0.00148	CcSEcCtD
Fenofibrate—Decreased appetite—Fluorouracil—colon cancer	0.000619	0.00146	CcSEcCtD
Fenofibrate—Alopecia—Capecitabine—colon cancer	0.000619	0.00146	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000615	0.00145	CcSEcCtD
Fenofibrate—Mental disorder—Capecitabine—colon cancer	0.000613	0.00145	CcSEcCtD
Fenofibrate—Feeling abnormal—Irinotecan—colon cancer	0.000612	0.00145	CcSEcCtD
Fenofibrate—Erythema—Capecitabine—colon cancer	0.000609	0.00144	CcSEcCtD
Fenofibrate—Malnutrition—Capecitabine—colon cancer	0.000609	0.00144	CcSEcCtD
Fenofibrate—Dysuria—Methotrexate—colon cancer	0.000609	0.00144	CcSEcCtD
Fenofibrate—Pain—Fluorouracil—colon cancer	0.000609	0.00144	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Irinotecan—colon cancer	0.000608	0.00144	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Methotrexate—colon cancer	0.000605	0.00143	CcSEcCtD
Fenofibrate—Body temperature increased—Vincristine—colon cancer	0.000603	0.00143	CcSEcCtD
Fenofibrate—Abdominal pain—Vincristine—colon cancer	0.000603	0.00143	CcSEcCtD
Fenofibrate—Flatulence—Capecitabine—colon cancer	0.000601	0.00142	CcSEcCtD
Fenofibrate—Erectile dysfunction—Methotrexate—colon cancer	0.0006	0.00142	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Methotrexate—colon cancer	0.000594	0.00141	CcSEcCtD
Fenofibrate—Back pain—Capecitabine—colon cancer	0.00059	0.00139	CcSEcCtD
Fenofibrate—Body temperature increased—Irinotecan—colon cancer	0.000588	0.00139	CcSEcCtD
Fenofibrate—Abdominal pain—Irinotecan—colon cancer	0.000588	0.00139	CcSEcCtD
Fenofibrate—Feeling abnormal—Fluorouracil—colon cancer	0.000587	0.00139	CcSEcCtD
Fenofibrate—Muscle spasms—Capecitabine—colon cancer	0.000586	0.00139	CcSEcCtD
Fenofibrate—Pneumonia—Methotrexate—colon cancer	0.000584	0.00138	CcSEcCtD
Fenofibrate—Infestation—Methotrexate—colon cancer	0.000581	0.00137	CcSEcCtD
Fenofibrate—Infestation NOS—Methotrexate—colon cancer	0.000581	0.00137	CcSEcCtD
Fenofibrate—Renal failure—Methotrexate—colon cancer	0.000571	0.00135	CcSEcCtD
Fenofibrate—Ill-defined disorder—Capecitabine—colon cancer	0.000566	0.00134	CcSEcCtD
Fenofibrate—Urticaria—Fluorouracil—colon cancer	0.000565	0.00134	CcSEcCtD
Fenofibrate—Conjunctivitis—Methotrexate—colon cancer	0.000564	0.00134	CcSEcCtD
Fenofibrate—Anaemia—Capecitabine—colon cancer	0.000563	0.00133	CcSEcCtD
Fenofibrate—Body temperature increased—Fluorouracil—colon cancer	0.000563	0.00133	CcSEcCtD
Fenofibrate—Hypersensitivity—Vincristine—colon cancer	0.000562	0.00133	CcSEcCtD
Fenofibrate—Sweating—Methotrexate—colon cancer	0.000557	0.00132	CcSEcCtD
Fenofibrate—Malaise—Capecitabine—colon cancer	0.00055	0.0013	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Methotrexate—colon cancer	0.000549	0.0013	CcSEcCtD
Fenofibrate—Vertigo—Capecitabine—colon cancer	0.000548	0.0013	CcSEcCtD
Fenofibrate—Hypersensitivity—Irinotecan—colon cancer	0.000548	0.0013	CcSEcCtD
Fenofibrate—Asthenia—Vincristine—colon cancer	0.000548	0.0013	CcSEcCtD
Fenofibrate—Leukopenia—Capecitabine—colon cancer	0.000546	0.00129	CcSEcCtD
Fenofibrate—Palpitations—Capecitabine—colon cancer	0.000539	0.00127	CcSEcCtD
Fenofibrate—Asthenia—Irinotecan—colon cancer	0.000533	0.00126	CcSEcCtD
Fenofibrate—Cough—Capecitabine—colon cancer	0.000532	0.00126	CcSEcCtD
Fenofibrate—Hypertension—Capecitabine—colon cancer	0.000526	0.00125	CcSEcCtD
Fenofibrate—Hypersensitivity—Fluorouracil—colon cancer	0.000524	0.00124	CcSEcCtD
Fenofibrate—Diarrhoea—Vincristine—colon cancer	0.000522	0.00124	CcSEcCtD
Fenofibrate—Hepatitis—Methotrexate—colon cancer	0.000521	0.00123	CcSEcCtD
Fenofibrate—Chest pain—Capecitabine—colon cancer	0.000519	0.00123	CcSEcCtD
Fenofibrate—Arthralgia—Capecitabine—colon cancer	0.000519	0.00123	CcSEcCtD
Fenofibrate—Myalgia—Capecitabine—colon cancer	0.000519	0.00123	CcSEcCtD
Fenofibrate—Pharyngitis—Methotrexate—colon cancer	0.000517	0.00122	CcSEcCtD
Fenofibrate—Anxiety—Capecitabine—colon cancer	0.000517	0.00122	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000515	0.00122	CcSEcCtD
Fenofibrate—Discomfort—Capecitabine—colon cancer	0.000513	0.00121	CcSEcCtD
Fenofibrate—Diarrhoea—Irinotecan—colon cancer	0.000509	0.0012	CcSEcCtD
Fenofibrate—Dry mouth—Capecitabine—colon cancer	0.000507	0.0012	CcSEcCtD
Fenofibrate—Dizziness—Vincristine—colon cancer	0.000505	0.00119	CcSEcCtD
Fenofibrate—Pruritus—Fluorouracil—colon cancer	0.000504	0.00119	CcSEcCtD
Fenofibrate—Visual impairment—Methotrexate—colon cancer	0.000502	0.00119	CcSEcCtD
Fenofibrate—Oedema—Capecitabine—colon cancer	0.000497	0.00118	CcSEcCtD
Fenofibrate—Infection—Capecitabine—colon cancer	0.000494	0.00117	CcSEcCtD
Fenofibrate—Dizziness—Irinotecan—colon cancer	0.000491	0.00116	CcSEcCtD
Fenofibrate—Nervous system disorder—Capecitabine—colon cancer	0.000488	0.00115	CcSEcCtD
Fenofibrate—Eye disorder—Methotrexate—colon cancer	0.000487	0.00115	CcSEcCtD
Fenofibrate—Diarrhoea—Fluorouracil—colon cancer	0.000487	0.00115	CcSEcCtD
Fenofibrate—Thrombocytopenia—Capecitabine—colon cancer	0.000487	0.00115	CcSEcCtD
Fenofibrate—Tachycardia—Capecitabine—colon cancer	0.000485	0.00115	CcSEcCtD
Fenofibrate—Vomiting—Vincristine—colon cancer	0.000485	0.00115	CcSEcCtD
Fenofibrate—Cardiac disorder—Methotrexate—colon cancer	0.000484	0.00114	CcSEcCtD
Fenofibrate—Skin disorder—Capecitabine—colon cancer	0.000483	0.00114	CcSEcCtD
Fenofibrate—Rash—Vincristine—colon cancer	0.000481	0.00114	CcSEcCtD
Fenofibrate—Hyperhidrosis—Capecitabine—colon cancer	0.000481	0.00114	CcSEcCtD
Fenofibrate—Dermatitis—Vincristine—colon cancer	0.000481	0.00114	CcSEcCtD
Fenofibrate—Headache—Vincristine—colon cancer	0.000478	0.00113	CcSEcCtD
Fenofibrate—Anorexia—Capecitabine—colon cancer	0.000474	0.00112	CcSEcCtD
Fenofibrate—Angiopathy—Methotrexate—colon cancer	0.000473	0.00112	CcSEcCtD
Fenofibrate—Vomiting—Irinotecan—colon cancer	0.000473	0.00112	CcSEcCtD
Fenofibrate—Dizziness—Fluorouracil—colon cancer	0.000471	0.00111	CcSEcCtD
Fenofibrate—Mediastinal disorder—Methotrexate—colon cancer	0.00047	0.00111	CcSEcCtD
Fenofibrate—Rash—Irinotecan—colon cancer	0.000469	0.00111	CcSEcCtD
Fenofibrate—Dermatitis—Irinotecan—colon cancer	0.000468	0.00111	CcSEcCtD
Fenofibrate—Headache—Irinotecan—colon cancer	0.000466	0.0011	CcSEcCtD
Fenofibrate—Hypotension—Capecitabine—colon cancer	0.000465	0.0011	CcSEcCtD
Fenofibrate—Alopecia—Methotrexate—colon cancer	0.000461	0.00109	CcSEcCtD
Fenofibrate—Mental disorder—Methotrexate—colon cancer	0.000457	0.00108	CcSEcCtD
Fenofibrate—Erythema—Methotrexate—colon cancer	0.000454	0.00107	CcSEcCtD
Fenofibrate—Malnutrition—Methotrexate—colon cancer	0.000454	0.00107	CcSEcCtD
Fenofibrate—Nausea—Vincristine—colon cancer	0.000453	0.00107	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000453	0.00107	CcSEcCtD
Fenofibrate—Vomiting—Fluorouracil—colon cancer	0.000453	0.00107	CcSEcCtD
Fenofibrate—Insomnia—Capecitabine—colon cancer	0.00045	0.00106	CcSEcCtD
Fenofibrate—Rash—Fluorouracil—colon cancer	0.000449	0.00106	CcSEcCtD
Fenofibrate—Dermatitis—Fluorouracil—colon cancer	0.000448	0.00106	CcSEcCtD
Fenofibrate—Paraesthesia—Capecitabine—colon cancer	0.000447	0.00106	CcSEcCtD
Fenofibrate—Headache—Fluorouracil—colon cancer	0.000446	0.00106	CcSEcCtD
Fenofibrate—Dyspnoea—Capecitabine—colon cancer	0.000443	0.00105	CcSEcCtD
Fenofibrate—Nausea—Irinotecan—colon cancer	0.000441	0.00104	CcSEcCtD
Fenofibrate—Back pain—Methotrexate—colon cancer	0.000439	0.00104	CcSEcCtD
Fenofibrate—Dyspepsia—Capecitabine—colon cancer	0.000438	0.00104	CcSEcCtD
Fenofibrate—Decreased appetite—Capecitabine—colon cancer	0.000432	0.00102	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Capecitabine—colon cancer	0.000429	0.00102	CcSEcCtD
Fenofibrate—Fatigue—Capecitabine—colon cancer	0.000429	0.00101	CcSEcCtD
Fenofibrate—Pain—Capecitabine—colon cancer	0.000425	0.00101	CcSEcCtD
Fenofibrate—Constipation—Capecitabine—colon cancer	0.000425	0.00101	CcSEcCtD
Fenofibrate—Nausea—Fluorouracil—colon cancer	0.000423	0.001	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—colon cancer	0.000421	0.000996	CcSEcCtD
Fenofibrate—Anaemia—Methotrexate—colon cancer	0.000419	0.000992	CcSEcCtD
Fenofibrate—Feeling abnormal—Capecitabine—colon cancer	0.00041	0.00097	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—colon cancer	0.000409	0.000968	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—colon cancer	0.000408	0.000965	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Capecitabine—colon cancer	0.000407	0.000962	CcSEcCtD
Fenofibrate—Leukopenia—Methotrexate—colon cancer	0.000406	0.000961	CcSEcCtD
Fenofibrate—Cough—Methotrexate—colon cancer	0.000396	0.000937	CcSEcCtD
Fenofibrate—Urticaria—Capecitabine—colon cancer	0.000395	0.000935	CcSEcCtD
Fenofibrate—Abdominal pain—Capecitabine—colon cancer	0.000393	0.00093	CcSEcCtD
Fenofibrate—Body temperature increased—Capecitabine—colon cancer	0.000393	0.00093	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—colon cancer	0.000386	0.000914	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—colon cancer	0.000386	0.000914	CcSEcCtD
Fenofibrate—Myalgia—Methotrexate—colon cancer	0.000386	0.000914	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000384	0.000908	CcSEcCtD
Fenofibrate—Discomfort—Methotrexate—colon cancer	0.000382	0.000903	CcSEcCtD
Fenofibrate—Infection—Methotrexate—colon cancer	0.000368	0.00087	CcSEcCtD
Fenofibrate—Hypersensitivity—Capecitabine—colon cancer	0.000366	0.000867	CcSEcCtD
Fenofibrate—Nervous system disorder—Methotrexate—colon cancer	0.000363	0.000859	CcSEcCtD
Fenofibrate—Thrombocytopenia—Methotrexate—colon cancer	0.000363	0.000858	CcSEcCtD
Fenofibrate—Skin disorder—Methotrexate—colon cancer	0.00036	0.000851	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methotrexate—colon cancer	0.000358	0.000847	CcSEcCtD
Fenofibrate—Asthenia—Capecitabine—colon cancer	0.000357	0.000844	CcSEcCtD
Fenofibrate—PPARA—Nuclear Receptors—HNF4A—colon cancer	0.000355	0.0659	CbGpPWpGaD
Fenofibrate—Anorexia—Methotrexate—colon cancer	0.000353	0.000835	CcSEcCtD
Fenofibrate—Pruritus—Capecitabine—colon cancer	0.000352	0.000833	CcSEcCtD
Fenofibrate—Hypotension—Methotrexate—colon cancer	0.000346	0.000819	CcSEcCtD
Fenofibrate—Diarrhoea—Capecitabine—colon cancer	0.00034	0.000805	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000337	0.000798	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—colon cancer	0.000335	0.000792	CcSEcCtD
Fenofibrate—Paraesthesia—Methotrexate—colon cancer	0.000333	0.000787	CcSEcCtD
Fenofibrate—Dyspnoea—Methotrexate—colon cancer	0.00033	0.000781	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—colon cancer	0.000329	0.000779	CcSEcCtD
Fenofibrate—Dizziness—Capecitabine—colon cancer	0.000329	0.000778	CcSEcCtD
Fenofibrate—Dyspepsia—Methotrexate—colon cancer	0.000326	0.000771	CcSEcCtD
Fenofibrate—Decreased appetite—Methotrexate—colon cancer	0.000322	0.000762	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—colon cancer	0.00032	0.000756	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—colon cancer	0.000319	0.000755	CcSEcCtD
Fenofibrate—Pain—Methotrexate—colon cancer	0.000317	0.000749	CcSEcCtD
Fenofibrate—Vomiting—Capecitabine—colon cancer	0.000316	0.000748	CcSEcCtD
Fenofibrate—Rash—Capecitabine—colon cancer	0.000314	0.000742	CcSEcCtD
Fenofibrate—Dermatitis—Capecitabine—colon cancer	0.000313	0.000741	CcSEcCtD
Fenofibrate—Headache—Capecitabine—colon cancer	0.000312	0.000737	CcSEcCtD
Fenofibrate—Feeling abnormal—Methotrexate—colon cancer	0.000305	0.000722	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methotrexate—colon cancer	0.000303	0.000716	CcSEcCtD
Fenofibrate—Nausea—Capecitabine—colon cancer	0.000295	0.000699	CcSEcCtD
Fenofibrate—Urticaria—Methotrexate—colon cancer	0.000294	0.000696	CcSEcCtD
Fenofibrate—Abdominal pain—Methotrexate—colon cancer	0.000293	0.000693	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—colon cancer	0.000293	0.000693	CcSEcCtD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.000281	0.0521	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Methotrexate—colon cancer	0.000273	0.000646	CcSEcCtD
Fenofibrate—Asthenia—Methotrexate—colon cancer	0.000266	0.000629	CcSEcCtD
Fenofibrate—Pruritus—Methotrexate—colon cancer	0.000262	0.00062	CcSEcCtD
Fenofibrate—Diarrhoea—Methotrexate—colon cancer	0.000253	0.000599	CcSEcCtD
Fenofibrate—Dizziness—Methotrexate—colon cancer	0.000245	0.000579	CcSEcCtD
Fenofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000242	0.045	CbGpPWpGaD
Fenofibrate—Vomiting—Methotrexate—colon cancer	0.000235	0.000557	CcSEcCtD
Fenofibrate—Rash—Methotrexate—colon cancer	0.000233	0.000552	CcSEcCtD
Fenofibrate—Dermatitis—Methotrexate—colon cancer	0.000233	0.000552	CcSEcCtD
Fenofibrate—Headache—Methotrexate—colon cancer	0.000232	0.000549	CcSEcCtD
Fenofibrate—Nausea—Methotrexate—colon cancer	0.00022	0.00052	CcSEcCtD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.000209	0.0388	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CHST4—colon cancer	0.000175	0.0324	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000169	0.0313	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—TOP1—colon cancer	0.000163	0.0303	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors—PPARG—colon cancer	0.000154	0.0286	CbGpPWpGaD
Fenofibrate—PPARA—PPAR Alpha Pathway—CCND1—colon cancer	0.000149	0.0276	CbGpPWpGaD
Fenofibrate—PPARA—REV-ERBA represses gene expression—EP300—colon cancer	0.000146	0.0271	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	0.000142	0.0264	CbGpPWpGaD
Fenofibrate—PPARA—RORA activates circadian gene expression—EP300—colon cancer	0.000141	0.0262	CbGpPWpGaD
Fenofibrate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000134	0.0249	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000122	0.0226	CbGpPWpGaD
Fenofibrate—PPARA—PPAR Alpha Pathway—MYC—colon cancer	0.000119	0.0221	CbGpPWpGaD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.000119	0.0221	CbGpPWpGaD
Fenofibrate—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.000103	0.0191	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	9.37e-05	0.0174	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—PPARG—colon cancer	8.77e-05	0.0163	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	8.02e-05	0.0149	CbGpPWpGaD
Fenofibrate—PPARA—Circadian Clock—EP300—colon cancer	7.51e-05	0.0139	CbGpPWpGaD
Fenofibrate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	7.34e-05	0.0136	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CA7—colon cancer	7.08e-05	0.0131	CbGpPWpGaD
Fenofibrate—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6.71e-05	0.0125	CbGpPWpGaD
Fenofibrate—PPARA—PPARA activates gene expression—PPARG—colon cancer	6.59e-05	0.0122	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	6.53e-05	0.0121	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	6.45e-05	0.012	CbGpPWpGaD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.4e-05	0.0119	CbGpPWpGaD
Fenofibrate—CYP3A4—Irinotecan Pathway—APC—colon cancer	6.18e-05	0.0115	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—PPARG—colon cancer	5.77e-05	0.0107	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—TYMS—colon cancer	5.74e-05	0.0107	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	5.74e-05	0.0106	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—DCC—colon cancer	5.42e-05	0.0101	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	4.99e-05	0.00926	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—HNF4A—colon cancer	4.85e-05	0.009	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—HNF4A—colon cancer	4.56e-05	0.00847	CbGpPWpGaD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.45e-05	0.00826	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	4.44e-05	0.00825	CbGpPWpGaD
Fenofibrate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	4.43e-05	0.00822	CbGpPWpGaD
Fenofibrate—PPARA—PPARA activates gene expression—EP300—colon cancer	4.31e-05	0.008	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	4.3e-05	0.00799	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ODC1—colon cancer	4.29e-05	0.00796	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CHST5—colon cancer	4.29e-05	0.00796	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	4.22e-05	0.00783	CbGpPWpGaD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	4.22e-05	0.00783	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—PPARG—colon cancer	4.07e-05	0.00755	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—CTNNB1—colon cancer	4.06e-05	0.00753	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—CDKN1A—colon cancer	3.96e-05	0.00736	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—TGFB1—colon cancer	3.28e-05	0.00609	CbGpPWpGaD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	3.16e-05	0.00586	CbGpPWpGaD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.93e-05	0.00545	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	2.91e-05	0.0054	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—EP300—colon cancer	2.66e-05	0.00494	CbGpPWpGaD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	2.57e-05	0.00477	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—ABCB1—colon cancer	2.42e-05	0.00449	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—HNF4A—colon cancer	2.33e-05	0.00433	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CA7—colon cancer	2.29e-05	0.00426	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—PPARG—colon cancer	2.11e-05	0.00391	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—PPARG—colon cancer	1.98e-05	0.00368	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—TP53—colon cancer	1.91e-05	0.00354	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CA7—colon cancer	1.87e-05	0.00347	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.77e-05	0.00329	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—CTNNB1—colon cancer	1.39e-05	0.00259	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.39e-05	0.00258	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CHST5—colon cancer	1.39e-05	0.00258	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ODC1—colon cancer	1.39e-05	0.00258	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—EP300—colon cancer	1.3e-05	0.00241	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—SRC—colon cancer	1.26e-05	0.00234	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CA7—colon cancer	1.23e-05	0.00229	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—VEGFA—colon cancer	1.23e-05	0.00228	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—NRAS—colon cancer	1.21e-05	0.00225	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—MYC—colon cancer	1.2e-05	0.00223	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.16e-05	0.00215	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ABCB1—colon cancer	1.13e-05	0.0021	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ODC1—colon cancer	1.13e-05	0.0021	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CHST5—colon cancer	1.13e-05	0.0021	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—TGFB1—colon cancer	1.13e-05	0.00209	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—TYMS—colon cancer	1.11e-05	0.00207	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—EGFR—colon cancer	1.11e-05	0.00205	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—KRAS—colon cancer	1.04e-05	0.00194	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—PPARG—colon cancer	1.01e-05	0.00188	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—HRAS—colon cancer	8.87e-06	0.00165	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.57e-06	0.00159	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PPARG—colon cancer	7.88e-06	0.00146	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—AKT1—colon cancer	7.84e-06	0.00145	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ODC1—colon cancer	7.46e-06	0.00139	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CHST5—colon cancer	7.46e-06	0.00139	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTGS2—colon cancer	6.2e-06	0.00115	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MYC—colon cancer	5.78e-06	0.00107	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.74e-06	0.00107	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—EP300—colon cancer	5.16e-06	0.000957	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.67e-06	0.000867	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.51e-06	0.000838	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—AKT1—colon cancer	4.01e-06	0.000744	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CA—colon cancer	3.81e-06	0.000708	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.75e-06	0.000697	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.67e-06	0.000682	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ABCB1—colon cancer	3.67e-06	0.000682	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—TYMS—colon cancer	3.61e-06	0.00067	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—AKT1—colon cancer	3.12e-06	0.000578	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.06e-06	0.000567	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ABCB1—colon cancer	2.99e-06	0.000555	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TYMS—colon cancer	2.94e-06	0.000545	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.78e-06	0.000516	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PPARG—colon cancer	2.56e-06	0.000474	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.26e-06	0.00042	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PPARG—colon cancer	2.08e-06	0.000386	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTGS2—colon cancer	2.01e-06	0.000373	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ABCB1—colon cancer	1.97e-06	0.000366	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TYMS—colon cancer	1.94e-06	0.00036	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—EP300—colon cancer	1.67e-06	0.00031	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTGS2—colon cancer	1.64e-06	0.000304	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PPARG—colon cancer	1.37e-06	0.000255	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—EP300—colon cancer	1.36e-06	0.000253	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CA—colon cancer	1.24e-06	0.00023	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTGS2—colon cancer	1.08e-06	0.0002	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—AKT1—colon cancer	1.01e-06	0.000188	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CA—colon cancer	1.01e-06	0.000187	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—EP300—colon cancer	8.98e-07	0.000167	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AKT1—colon cancer	8.22e-07	0.000153	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CA—colon cancer	6.64e-07	0.000123	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AKT1—colon cancer	5.42e-07	0.000101	CbGpPWpGaD
